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Abstract 
Background and objectives: Laryngeal mask airway (LMA), which has been used frequently 
in airway management, can cause laryngopharyngeal injury and morbidity. In this trial, we 
compare the macroscopic changes on laryngopharyngeal structures and the postoperative 
laryngopharyngeal morbidity by using LMA supreme with LMA proseal in children.
Methods: We divided patients into two groups. We inserted size three LMA proseal into the 
first group and size three LMA supreme into the second group. Before LMA insertion and after 
LMA removal, we performed direct laryngoscopy on the patients. We compared hyperemia, 
mucosal injury and blood staining on LMA removal, as well as insertion time, rate of success 
in gastric tube insertion on the first attempt, nausea, vomiting, and sore throat between the 
two groups.
Results: We recorded no significant differences between the two groups for mean operation 
time, sex, age, weight, rate of success in gastric tube insertion on first attempt, nausea, 
vomiting, sore throat and mucosal injury. Mean insertion time for the LMA proseal group was 
significantly longer than the LMA supreme group (p = 0.0001). The ratio of blood staining on 
LMA removal was significantly higher in the LMA proseal group than the LMA supreme group 
(p = 0.034). The patients with blood staining on LMA removal exhibited significantly more 
mucosal hyperemia and injury than the patients with clear LMA (p = 0.0001, p = 0.020).
Conclusion: LMA supreme insertion is faster and easier than LMA proseal and causes less 
laryngopharyngeal injury than LMA proseal in children.
© 2013 Sociedade Brasileira de Anestesiologia. Published by Elsevier Editora Ltda.  
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Introduction
Supraglottic airway devices have been used for airway 
management in modern anaesthesia. LMA, which was designed 
by Dr Archie Brain (UK) in 1981, has been successfully used as 
an airway device in both predicted and unpredicted airway 
difficulties.1,2 Since the first LMA model, new generation LMA 
models have been developed.3 LMA supreme was designed 
in 2007 to combine the desirable features of ILMA and LMA 
proseal. It is made of latex-free medical grade polyvinyl 
chloride (PVC) for single use. Elliptical and anatomically 
shaped, it facilitates easy insertion, without placing fingers 
in the patients’ mouths or requiring an introducer tool. It 
has a gastric access using a lubricated gastric tube up to 
size 16 F.4,5 The rigid anatomic shape of ILMA facilitates 
easy insertion of the device without the need for placing 
fingers in the patient’s mouth, but does not offer gastric 
access. LMA proseal is flexible and requires placing fingers 
in the patient’s mouth or an introducer tool for insertion. 
Several studies have macroscopically investigated the 
trauma in the laryngopharyngeal structures caused by LMA 
classic and LMA proseal in adults,6 but no study has so far 
investigated the trauma caused by supreme LMA in children. 
The primary objective was to compare laryngopharyngeal 
trauma and macroscopic changes related to LMA proseal 
with LMA supreme in children. The secondary aim was to 
compare postoperative laryngopharyngeal morbidity and 
complications due to LMA proseal with LMA supreme. 
Methods
After obtaining the Ethics Committee’s approval and 
patients’ parents’ written informed consent, the study 
was conducted according to the Declaration of Helsinki. 
This prospective and randomized study was performed in 
80 patients over a period of eight months. For this study, 
we selected a group of ASA I patients who were scheduled 
for minor pelvic or genitourinary operations and weighed 
between 30-50 kg. Exclusion criteria included patients who 
had gastroesophageal reflux, risk of aspiration, an airway 
infection in the last six weeks and known or predicted 
airway. Thirty minutes before the operation, patients 
were interned to the premedication unit. We performed 
intravenous (iv) catheterisation on these patients with a 
22-gauge iv catheter, and started 0.9% NaCl fluid infusion. 
We gave preoperative 0.05 mg•kg-1 iv midazolam as 
premedication. We monitored non-invasive systemic artery 
pressure, ECG and pulse oximetry of the patients interned 
in the operation room. We divided patients into two groups 
randomly. We performed randomisation using a sealed 
envelope method. We performed anesthesia induction 
with 2 mg•kg-1 propofol and 1 μg•kg-1 fentanyl. We did not 
use neuromuscular blocking agents. After induction and 
before LMA insertion, an anesthetist with more than five 
years experience smoothly performed direct laryngoscopy. 
We used a size three blade for direct laryngoscopy. We 
excluded the patients who had hyperemia and infection 
findings in direct laryngoscopy from this trial. Another 
anesthetist - also with more than five years experience - 
inserted lubricated LMA, The anesthetist who performed 
the direct laryngoscopy did not see the inserted LMA’s type. 
We used a size three LMA proseal (Laryngeal Mask Company 
Limited, Le Rocher, Victoria, Mahe, Seychelles) on the 
first group and size three LMA supreme (Laryngeal Mask 
Company Limited, Le Rocher, Victoria, Mahe, Seychelles) on 
the second group. LMA proseal was inserted by finger. We 
used neither an introducer tool nor fingers in LMA supreme 
insertion. We included in the trial the patients into whom 
the LMA had been inserted on the first attempt. We excluded 
repeated attempts from the trial. We connected the LMA 
to a circle breathing system. We maintained anaesthesia 
with 2% sevoflurane and 40% medical air/O2 mixture. We 
performed controlled ventilation on the patients as 10 
mL•kg-1 tidal volume, 12•min-1 ventilation rate and 1:2 
for inspiratory:expiratory rate. We monitored LMA cuff 
pressure for lower than 60 cmH2O by using a cuff pressure 
monitor (Endotest; Rüsch, Kernen, Germany) and controlled 
every 10 minutes. After the operation, when spontaneous 
respiration occurred in deep anaesthesia, the anesthetist 
who had inserted it removed the LMA. We recorded blood 
staining on LMA removal. The anaesthetist who performed 
the direct laryngoscopy before LMA insertion inspected the 
laryngopharyngeal structures again in direct laryngoscopy. 
We recorded the presence of hyperemia and mucosal injury 
numerically as below:
Hyperemia present in oropharynx: 1
No hyperemia in oropharynx: 0
Mucosal injury present: 1
No mucosal injury: 0
Blood staining on LMA removal: 1
No blood on LMA removal: 0
We recorded LMA insertion time, success in inserting 
the gastric tube on the first attempt, presence of nausea, 
vomiting, laryngospasm and sore throat in the first hour 
postoperatively.
Results
The distribution of sex (p = 0.823) and mean age (p = 
0.225) (Table 1) between the LMA proseal and LMA supreme 
groups were similar. There was no significant difference 
between groups for mean weight and operation time (p 
= 0.933, p = 0.882). We found mean insertion time of 
the LMA proseal group to be significantly longer than the 
LMA supreme group (p = 0.0001) (Table 2). We recorded 
no significant differences between the two groups for 
incidence of nausea (p = 0.723), vomiting (p = 0.723), 
sore throat (p = 0.456) and rate of success in inserting the 
gastric tube on first attempt (p = 0.360) (Table 3). There 
was no difference between groups according to the mucosal 
hyperemia (p = 0.366) and mucosal injury (p = 0.090). Rate 
of blood staining on removal of the LMA proseal group was 
significantly higher than the LMA supreme group’s rate (p = 
0.034) (Table 4). We found incidence of mucosal hyperemia 
in 12 (92.3%) of the patients with blood staining on LMA 
removal, significantly more than the patients with clear 
LMA 22 (32.8%) (p = 0.0001) (Table 5). The patients with 
blood staining on LMA removal had mocosal injury 3 (23.1%) 
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significantly more than the patients with clear LMA 3 (4.5%) 
(p = 0.020) (Table 5). 
We calculated the sample sizes with the assumption of at 
least of 30% possible difference between any two groups. 
Therefore, we allocated 40 patients into each group in 
order to obtain an alpha error of 5% and statistical power 
of 80%.
Statistical analyses
In this study, statistical analyses were performed with the NCSS 
(Number Cruncher Statistical System) 2007 Statistical Software 
(Utah, USA) program. For the evaluation of obtained data, 
along with descriptive statistical methods (mean, standard 
deviation), an independent t-test was used for comparison 
Table 1 The distribution of sex and age in groups.
 LMA proseal group LMA supreme group p
 n = 40  n = 40
Age 11.65 ± 2.37  12.3 ± 2.39  0.225
Sex     
Male 19 47.50% 20 50.00% 0.823
Female 21 52.50% 20 50.00%
LMA, laryngeal mask airway.
Table 2 Mean weight, operation time and laryngeal mask airway insertion time of groups.
 LMA proseal group LMA supreme group p
 n = 40 n = 40
Weight 39.88 ± 6.75 40 ± 6.45 0.933
Operation time 48.63 ± 14.76 48.13 ± 15.39 0.882
LMA insertion time 17.18 ± 1.88 12.03 ± 1.67 0.0001*
LMA, laryngeal mask airway.
* p < 0.05 (mean ± standard deviation).
Table 3 Incidence of nausea, vomiting, coughing, sore throat and ratio of success in gastric tube insertion on first attempt 
among groups.
 LMA proseal group  LMA supreme group  p
 n = 40  n = 40
Nausea     
 Absent 35 87.50% 36 90.00% 0.723
 Present 5 12.50% 4 10.00%
Vomiting     
 Absent 35 87.50% 36 90.00% 0.723
 Present 5 12.50% 4 10.00%
Sore throat     
 Absent 35 87.50% 37 92.50% 0.456
 Present 5 12.50% 3 7.50%
Gastric tube insertion     
 Absent 30 76.90% 34 85.00% 0.360
 Present 9 23.10% 6 15.00%
 Present 4 10.00% 5 12.50%
LMA, laryngeal mask airway.
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between the two groups and a chi-square test was used for 
comparison of qualitative parameters. We considered results 
statistically significant when p value was less 0.05.
Discussion
Theoretically, when the cuff pressure is higher than the 
pharyngeal mucosal capillary perfusion pressure of the LMA-
inserted patients, mucosal blood flow reduces and direct 
tissue trauma occurs. The same happens in the tracheal tube-
inserted patients.6 In the histopathologic studies performed 
on dogs by Martin et al.,7 the authors reported that high LMA 
cuff pressure caused minor changes to the laryngopharyngeal 
mucosa. These minor laryngopharyngeal injuries may explain 
the patients’ complaints of sore throat, hoarseness and 
disphagia. Increased LMA cuff pressures cause a powerful 
compression of the laryngopharyngeal structures, resulting 
in injuries of the lingual, hypoglossal, recurrent nerves and 
lingual artery compression. Therefore, they recommended 
maintaining LMA cuff pressure lower than 60 cmH2O to 
reduce the possibility of these complications.6,7 Seet et al.8 
reported that an intracuff pressure lower than 44 mmHg 
reduced laryngopharyngeal morbidity. In our study, the cuff 
pressures were monitored in both groups and maintained at 
lower than 60 cmH2O by controlling them every 10 minutes. 
Although the mucosal hyperemia was seen with direct 
laryngoscopy more frequently in the LMA proseal group, 
we found no significant difference between the two groups 
in our study. We obtained the histopathologic evidences 
in animal studies which investigated the effects of long-
term use of LMA proseal’s on laryngopharyngeal mucosa. 
Although we found minor mucosal changes, we observed 
no mucosal injury in the use of LMA proseal over nine hours 
on pigs. However, we did observe mucosal injuries when 
using LMA proseal’s over 12 hours.9 In our study, the longest 
operation time was 80 minutes in the LMA supreme group 
and 90 minutes in the LMA proseal group. None of these 
complications occurred in either group. 
The incidence of sore throat ranged from 5.8% up to 34% 
for the LMA and it was 10% for the LMA proseal.6 Chia et 
al.10 suggested the importance of using larger air volume 
and larger size LMA as factors that cause postoperative 
laryngopharyngeal morbidity. Grady et al.11 demonstrated 
that sore throat incidence was higher when using large 
size LMA. In our study, we planned to avoid the possible 
differences of morbidity by using size three LMA in 
both groups. Soar throat incidence during the first hour 
postoperatively was 12.5% in the LMA proseal group and 7.5% 
in the LMA supreme group, an insignificant difference.
Table 5 Comparison of the blood staining on laryngeal mask airway removal with mucosal hyperemia and mucosal injury.
  Blood on LMA (–)  Blood on LMA (+)  p
  n = 67  n = 13
Mucosal hyperemia     
 Absent  45 67.20% 1 7.70% 0.0001*
 Present  22 32.80% 12 92.30%
Mucosal injury     
 Absent  64 95.50% 10 76.90% 0.020* 
 Present  3 4.50% 3 23.10%
LMA, laryngeal mask airway.
* p < 0.05.
Table 4 Rates of mucosal hyperemia, mucosal injury and blood staining on laryngeal mask airway removal among the groups.
 LMA proseal group  LMA supreme group p
 n = 40  n = 40
Mucosal hyperemia     
 Absent 21 52.50% 25 62.50% 0.366
 Present 19 47.50% 15 37.50%
Blood staining on LMA removal     
 Absent 30 75.00% 37 92.50% 0.034*
 Present 10 25.00% 3 7.50%
Mucosal injury     
 Absent 35 87.50% 39 97.50% 0.090
 Present 5 12.50% 1 2.50%
LMA, laryngeal mask airway.
* p < 0.05. 
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Timmermann et al.12,13 reported that the LMA supreme 
was easy to insert, provided optimal laryngeal view and 
caused low airway morbidity according to their fiberoptic 
bronchoscopy performed study. Tan et al.14 suggested that 
the mean insertion time was 15 seconds (12-18 seconds) 
for LMA supreme in their study. In this study, incidence of 
blood staining on LMA removal was 7%. A controlled and 
randomized study like ours was conducted by Jagannathan 
et al.15 In this study, the authors recorded insertion time, 
easiness of insertion, possibility of gastric tube insertion and 
complications of LMA supreme size two with LMA proseal 
size two. There was no statistically significant difference 
between parameters compared in both groups. The LMA 
supreme’s mean insertion time was significantly shorter than 
the LMA proseal’s in our study. The shortest and the longest 
insertion times were 9 seconds and 16 seconds, respectively, 
for the LMA supreme, and 15 seconds and 21 seconds, 
respectively, for the LMA proseal. Although we did not find 
macroscopic bleeding in any patient’s direct laryngoscopy, 
the incidence of blood staining on removal of the LMA 
proseal group (25%) was significantly higher than in the LMA 
supreme group (7.5%). The presence of mucosal hyperemia 
and mucosal injury in the patients with blood staining on 
LMA removal was significantly higher than the patients with 
clear LMA. According to these data, the anatomic shape of 
LMA supreme, which is facilitating easy insertion, results in 
lower rates of laryngopharyngeal injury. 
Eschertzhuber et al.16 reported that the rate of LMA 
insertion success on the first attempt was 92% for LMA 
proseal and 95% for LMA supreme in their study. The rate 
of gastric tube insertion success on the first attempt was 
91% in LMA proseal and 92% in LMA supreme in the same 
study. We included only the LMA-inserted patients in the 
first attempt in our study because repeated attempts could 
induce laryngopharyngeal trauma. In our study, the rate 
of gastric tube insertion success in the first attempt was 
91% in the LMA proseal group and 92% in the LMA supreme 
group. Incidences of coughing, nausea and vomiting were 
similar in both groups. 
In conclusion, it was easier and faster to determine the 
LMA supreme insertion than the LMA proseal in children. 
Although both had similar postoperative complications, the 
LMA supreme caused less laryngopharyngeal injury than 
the LMA proseal. The LMA supreme could be used safely in 
elective surgery.
Limitations of the study
Direct laryngoscopy has the possibility of inducing 
postoperative morbidity. But in our study, there would not 
be any difference in morbidity rates because we performed 
direct laryngoscopy in all of the patients. Significant results 
in this study (such as LMA insertion time or blood staining 
on LMA removal) were objective findings. Also there was no 
significant difference between two groups in postoperative 
complications.
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